Biotechnology in China

Biotechnology in China industry profile is an essential resource for top-level data and analysis covering the Biotechnology industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

• Contains an executive summary and data on value, volume and/or segmentation
• Provides textual analysis of Biotechnology in China’s recent performance and future prospects
• Incorporates in-depth five forces competitive environment analysis and scorecards
• Includes a five-year forecast of Biotechnology in China
• The leading companies are profiled with supporting key financial metrics
• Supported by the key macroeconomic and demographic data affecting the market

Highlights

• Detailed information is included on market size, measured by value and/or volume
• Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

Why you should buy this report

• Spot future trends and developments
• Inform your business decisions
• Add weight to presentations and marketing materials
• Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this market from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2009 annual average exchange rates.

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

Contents

EXECUTIVE SUMMARY

MARKET OVERVIEW

Market definition
Research highlights
Market analysis

MARKET VALUE

MARKET SEGMENTATION I

MARKET SEGMENTATION II

FIVE FORCES ANALYSIS

Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry

LEADING COMPANIES

China National Biotec Corp.
Shanghai Kehua Bio-engineering Co., Ltd
Sinovac Biotech Ltd.
Wuxi Pharmatech (Cayman) Inc.

MARKET FORECASTS

Market value forecast

MACROECONOMIC INDICATORS

APPENDIX

Methodology
Industry associations
Related Datamonitor research
Disclaimer

ABOUT DATAMONITOR

Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES

Table 1: China biotechnology market value: $ billion, 2005–09
Table 2: China biotechnology market segmentation I:% share, by value, 2009
Table 3: China biotechnology market segmentation II: % share, by value, 2009
Table 4: China National Biotec Corp.: key facts
Table 5: Shanghai Kehua Bio-engineering Co., Ltd: key facts
Table 6: Sinovac Biotech Ltd.: key facts
Table 7: Sinovac Biotech Ltd.: key financials ($)
Table 8: Sinovac Biotech Ltd.: key financial ratios
Table 9: Wuxi Pharmatech (Cayman) Inc.: key facts
Table 10: Wuxi Pharmatech (Cayman) Inc.: key financials ($)
Table 11: Wuxi Pharmatech (Cayman) Inc.: key financial ratios
Table 12: China biotechnology market value forecast: $ billion, 2009–14
Table 13: China size of population (million), 2005–09
Table 14: China gdp (constant 2000 prices, $ billion), 2005–09
Table 15: China gdp (current prices, $ billion), 2005–09
Table 16: China inflation, 2005–09
Table 17: China consumer price index (absolute), 2005–09
Table 18: China exchange rate, 2005–09

LIST OF FIGURES

Figure 1: China biotechnology market value: $ billion, 2005–09
Figure 2: China biotechnology market segmentation I:% share, by value, 2009
Figure 3: China biotechnology market segmentation II: % share, by value, 2009
Figure 4: Forces driving competition in the biotechnology market in China, 2009
Figure 5: Drivers of buyer power in the biotechnology market in China, 2009
Figure 6: Drivers of supplier power in the biotechnology market in China, 2009
Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in China, 2009
Figure 8: Factors influencing the threat of substitutes in the biotechnology market in China, 2009
Figure 9: Drivers of degree of rivalry in the biotechnology market in China, 2009
Figure 10: Sinovac Biotech Ltd.: revenues & profitability
Figure 11: Sinovac Biotech Ltd.: assets & liabilities
Figure 12: Wuxi Pharmatech (Cayman) Inc.: revenues & profitability
Figure 13: Wuxi Pharmatech (Cayman) Inc.: assets & liabilities
Figure 14: China biotechnology market value forecast: $ billion, 2009–14
Skip to top